We are live on ! Find out more
PROK icon

ProKidney
PROK

80 hedge funds and large institutions have $232M invested in ProKidney in 2022 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 22 increasing their positions, 11 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 11

2.04% more ownership

Funds ownership: 89.42% → 91.45% (+2%)

4% more capital invested

Capital invested by funds: $223M → $232M (+$9.22M)

11% less funds holding

Funds holding: 90 → 80 (-10)

42% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 24

Holders
80
Holders Change
-10
Holders Change %
-11.11%
% of All Funds
1.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
22
Reduced
11
Closed
24
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$10.1M
2
ACA
Arena Capital Advisors
California
+$7.27M
3
6CM
683 Capital Management
New York
+$4.93M
4
HSBC Holdings
HSBC Holdings
United Kingdom
+$4.39M
5
Millennium Management
Millennium Management
New York
+$4.33M

Top Sellers

Rank Fund Capital Flow
1
PWAM
Park West Asset Management
California
-$10.9M
2
FC
Finepoint Capital
Massachusetts
-$9.7M
3
RIA
RP Investment Advisors
Ontario, Canada
-$5.33M
4
LCM
LH Capital Markets
New York
-$4.95M
5
Franklin Resources
Franklin Resources
California
-$3.96M
Name Holding Trade Value Shares
Change 		Change in
Stake
PMAM
51
Picton Mahoney Asset Management
Ontario, Canada
$990K – – –
SGM
52
Seven Grand Managers
New York
$990K +$986K +100,000 New
LCG
53
Luxor Capital Group
New York
$988K -$1.33M -134,952 -57%
DCM
54
Dupont Capital Management
Delaware
$988K – – –
AAI
55
Aequim Alternative Investments
California
$988K +$2.15K +218 +0.2%
FTCM
56
First Trust Capital Management
Illinois
$964K +$960K +97,400 New
CCM
57
CAAS Capital Management
New York
$946K – – –
Walleye Capital
58
Walleye Capital
New York
$855K – – –
CL
59
CSS LLC
Illinois
$830K +$826K +83,779 New
TCM
60
Tenor Capital Management
New York
$743K – – –
BFM
61
Boothbay Fund Management
New York
$602K +$375K +38,008 +166%
SIM
62
Sandia Investment Management
Massachusetts
$495K – – –
SCM
63
Shaolin Capital Management
Florida
$495K – – –
Walleye Trading
64
Walleye Trading
New York
$481K – – –
WRBC
65
W.R. Berkley Corp
Connecticut
$479K -$15.8K -1,601 -3%
Citigroup
66
Citigroup
New York
$465K -$986 -100 -0.2%
SSA
67
Schonfeld Strategic Advisors
New York
$424K +$423K +42,852 New
Bank of Nova Scotia
68
Bank of Nova Scotia
Ontario, Canada
$396K – – –
CAC
69
Cowen and Company
New York
$378K -$2.8M -283,752 -88%
RL
70
RPO LLC
Connecticut
$338K +$337K +34,138 New
Verition Fund Management
71
Verition Fund Management
Connecticut
$211K – – –
Mirae Asset Global Investments
72
Mirae Asset Global Investments
South Korea
$210K -$296K -30,000 -59%
Royal Bank of Canada
73
Royal Bank of Canada
Ontario, Canada
$206K +$7.89K +800 +4%
CCM
74
Condor Capital Management
New Jersey
$111K +$53.6K +5,440 +94%
CAPTRUST Financial Advisors
75
CAPTRUST Financial Advisors
North Carolina
$99K – – –
1 2
3
4 5

PROK Hedge Fund Activity: Q1 2022 in Review

80 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in ProKidney (PROK) for Q1 2022, worth a combined $232M — up 4.1% from $223M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of PROK and 14 opened new positions — a net loss of 10 holders — while 11 trimmed existing stakes and 22 added.

The largest buyer was Citadel Advisors, adding an estimated $10.1M. The largest seller was Park West Asset Management, exiting entirely with an estimated $10.9M sold.

  • 80 institutional investors held ProKidney (PROK) as of Q1 2022, down from 90 in Q4 2021.
  • Funds reported $232M of ProKidney stock for Q1 2022, up 4.1% quarter-over-quarter.
  • 14 funds opened new ProKidney positions in Q1 2022 and 24 closed out, a net change of -10 holders.
  • The largest ProKidney buyer in Q1 2022 was Citadel Advisors, an estimated $10.1M added.
  • The largest ProKidney seller in Q1 2022 was Park West Asset Management, an estimated $10.9M sold.

Based on aggregated 13F filings for Q1 2022.